Schnitzbauer, A., Filmann, N., Adam, R., Bachellier, P., Bechstein, W. O., Becker, T., . . . Geissler, E. K. (2020). mTOR inhibition is most beneficial after liver transplantation for hepatocellular carcinoma in patients with active tumors. Annals of surgery, 272(5), . https://doi.org/10.1097/SLA.0000000000004280
Chicago-Zitierstil (17. Ausg.)Schnitzbauer, Andreas, et al. "MTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients with Active Tumors." Annals of Surgery 272, no. 5 (2020). https://doi.org/10.1097/SLA.0000000000004280.
MLA-Zitierstil (9. Ausg.)Schnitzbauer, Andreas, et al. "MTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients with Active Tumors." Annals of Surgery, vol. 272, no. 5, 2020, https://doi.org/10.1097/SLA.0000000000004280.